{"id":"https://genegraph.clinicalgenome.org/r/bcef580a-7319-42f8-815e-53cacf0ccf0dv1.0","type":"EvidenceStrengthAssertion","dc:description":"SPRED1 was first reported in relation to autosomal dominant Legius syndrome in 2007 (Brems et al., PMID 17704776). At least 63 variants (e.g. missense, in-frame indel, nonsense, frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 21 probands in 2 publications (PMIDs: 17704776, 21089071). Variants in this gene segregated with disease in 35 additional family members. The mechanism for disease is  haploinsufficiency as demonstrated by patient variants and experimental evidence (PMIDs: 17704776, 27313208, 27503857). This gene-disease association is supported by a mouse model, functional alteration studies investigating heterologously expressed patient variants and coimmunoprecipitation assays with NF1, BRAF and KRAS. In summary SPRED1 is definitively associated with autosomal dominant Legius syndrome.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/bcef580a-7319-42f8-815e-53cacf0ccf0d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10021","date":"2019-01-24T05:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ace6b3f4-6549-4ba4-a8fe-4b71e0f9566c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"De novo variant found to suppress EGF induced ELLK-1 dependent transcription activation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa8c48b0-edef-4690-a3fc-7a33460c3e70","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21089071","rdfs:label":"Denayer family 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"detectionMethod":"SPRED1 sequencing","firstTestingMethod":"PCR","phenotypeFreeText":"hypertelorism, downslanting palpebral fissures, ptosis, low implanted posteriorly rotated ears, low posterior hairline, mild pterygium colli, pectus carinatum/excvatum, motor and language delay,  learning difficulties, ADHD, eczema first eyar, asthma, strabismus","phenotypes":["obo:HP_0000316","obo:HP_0000358","obo:HP_0007018","obo:HP_0000766","obo:HP_0000750","obo:HP_0002162","obo:HP_0007687","obo:HP_0000465","obo:HP_0000494","obo:HP_0000964","obo:HP_0000486"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ace6b3f4-6549-4ba4-a8fe-4b71e0f9566c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21089071","allele":{"id":"https://genegraph.clinicalgenome.org/r/cda2164a-643b-4341-95b8-ee87c6ec3388","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.38299433G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391934022"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89a18255-288c-4bdd-847a-b3b90927a34d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is a convincing LOF variant that segregated in a family with familial Legius syndrome.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9541855c-b8d5-4aaa-aada-c7e7f0a3ba84","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL1 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequencing of SPRED1 gene","firstTestingMethod":"PCR","phenotypeFreeText":"cafe au lait spots, multiple lipomas, macrocephaly, noonan-like face, mild pectus excavatum, hemihyperplasia, pseudotumor orbitae","phenotypes":["obo:HP_0001012","obo:HP_0000767","obo:HP_0000256","obo:HP_0000957","obo:HP_0005323"],"previousTesting":true,"previousTestingDescription":"excluded linkage to the NF1 region and conducted likage to narrow down the disease locus between D15S1040 and D15S659","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/89a18255-288c-4bdd-847a-b3b90927a34d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4f68dec-a0eb-4ba5-84f6-76fcfa8429e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152594.2(SPRED1):c.349C>T (p.Arg117Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251949"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/92ae897c-cefc-4a59-9604-63e11f958ee3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is predicted to cause a stop codon in the last exon of SPRED1, therefore it should be downgraded from a complete null score as it is still predicted to cause the loss of 123 amino acids.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f134cbd-93dc-4a10-b15c-5e55d0bd082e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UAB48","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"detectionMethod":"SPRED1 following linkage analysis","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"family history of CAL spots","previousTesting":true,"previousTestingDescription":"NF1 exclusion and linkage analysis","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/92ae897c-cefc-4a59-9604-63e11f958ee3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","allele":{"id":"https://genegraph.clinicalgenome.org/r/14134a11-2674-491a-8794-9e9ca59f689a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.38351293A>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391933642"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3b5e3df3-2291-4bfe-a858-d38d9939fef4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is predicted to cause a frameshift by skipping exon 4, an out of frame exon, and therefore is a predicted null variant. Variant is absent from gnomAD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c937234b-d135-4b00-a10a-aee015fcd927","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL3 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"SPRED1 sequencing exclusion of NF1","firstTestingMethod":"PCR","phenotypeFreeText":"learning problems, mild supravalvular pulmonic stenosis, learning problems, mild pectus excavatum, learning problems, features consisent with Noonan syndrome","phenotypes":"obo:HP_0000767","previousTesting":true,"previousTestingDescription":"Exclusion of NF1, linkage analysis","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3b5e3df3-2291-4bfe-a858-d38d9939fef4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","allele":{"id":"https://genegraph.clinicalgenome.org/r/291dd7ae-38c3-4235-ab5a-262a8eb822ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.38324810G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391932384"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/090da6ce-aaa3-442f-9587-8e6caa97b07f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Null variant predicted to cause LOF in patient.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78212322-92eb-41da-a113-5f1f1e76ad2f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL4 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"SPRED1 sequencing","firstTestingMethod":"PCR","phenotypeFreeText":"Noonan-like face, loose integument, two lipomas, appendicular skin tumor, VUJ-stenosis, nephrolithiasis","phenotypes":["obo:HP_0000787","obo:HP_0008069","obo:HP_0001012"],"previousTesting":true,"previousTestingDescription":"NF1 exclusion and linkage analysis","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/090da6ce-aaa3-442f-9587-8e6caa97b07f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4f68dec-a0eb-4ba5-84f6-76fcfa8429e7"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/902d547c-16aa-4a3c-a818-09a8614a0852_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is predicted to cause a stop codon but it is less than 50 bp away from the end of the penultimate exon and therefore should not be assumed to cause NMD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68aef5ff-a5d7-493c-9d63-13caf0d99691","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL5 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"SPRED1 sequenced after linkage analysis","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Wilms tumor, tubular colonadenoma, paroxysmal, atrial tachycardia, two lipomas","phenotypes":["obo:HP_0006671","obo:HP_0002667","obo:HP_0001012"],"previousTesting":true,"previousTestingDescription":"NF1 exclusion and linkage analysis","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/902d547c-16aa-4a3c-a818-09a8614a0852_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","allele":{"id":"https://genegraph.clinicalgenome.org/r/9cb8f743-13dd-4a49-8df4-c38086d96635","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152594.2(SPRED1):c.643C>T (p.Gln215Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251953"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e0009f9f-c7b5-45c9-a7b2-4c2864646a25_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is predicted to cause a frameshift that leads to NMD. While there is no sequencing information for the rest of the family, there is a note in the paper that this individual had a family history of CAL spots.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da3d7db3-e6b1-4971-917f-fb1b3e33c3d8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UAB15","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"detectionMethod":"exclusion of NF1 variants and sequencing of SPRED1","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"familial history of CAL spots","previousTesting":true,"previousTestingDescription":"exclusion of NF1 variants","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e0009f9f-c7b5-45c9-a7b2-4c2864646a25_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","allele":{"id":"https://genegraph.clinicalgenome.org/r/0d44d6ee-a2e5-4c35-85c7-6d864f809e8f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152594.2(SPRED1):c.796_797delAT (p.Met266Valfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/220172"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1909316f-a291-4ca7-9e7f-a372f1a414f1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant is predicted to cause a complete null variant in a sporadic case of Legius syndrome","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2052dd9-7c95-4a6c-b515-f88c5f1ef90e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21089071","rdfs:label":"Denayer family 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"detectionMethod":"Sequencing of SPRED1","firstTestingMethod":"PCR","phenotypeFreeText":"Legius syndrome; inguinal freckling, hypertelorism, normal psychomotor development, dyslexia, congential hypothyroidism","phenotypes":["obo:HP_0010522","obo:HP_0000851","obo:HP_0000316","obo:HP_0030052"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1909316f-a291-4ca7-9e7f-a372f1a414f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21089071","allele":{"id":"https://genegraph.clinicalgenome.org/r/42c2b32c-385f-48a9-ab67-4e13bfd08e86","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152594.2(SPRED1):c.52C>T (p.Arg18Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391933819"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/005102f6-7341-4e31-9925-4a30796c89c7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Convincing null variant identified in 1/8724 African alleles in gnomAD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd90cdc8-69ed-412f-8205-803f0ed5f082","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL2 Proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequencing of the SPRED1 gene","firstTestingMethod":"PCR","phenotypeFreeText":"cataract, multiple lipomas, non-small cell lung cancer, learning problems, ADHD, eczema, slow psychomotor development","phenotypes":["obo:HP_0001249","obo:HP_0001012","obo:HP_0000518","obo:HP_0007018","obo:HP_0030358","obo:HP_0000964"],"previousTesting":true,"previousTestingDescription":"exclusion of NF1 variants and linkage analysis","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/005102f6-7341-4e31-9925-4a30796c89c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","allele":{"id":"https://genegraph.clinicalgenome.org/r/16c46809-7624-4a27-8790-29ad03b7ccbe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152594.2(SPRED1):c.70C>T (p.Arg24Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251951"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43f6ac44-8706-4245-87d4-c76a93dd1578_proband_segregation","type":"FamilyCosegregation","dc:description":"Linkage followed by sequencing of SPRED1","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL1","estimatedLodScore":6.02,"family":{"id":"https://genegraph.clinicalgenome.org/r/43f6ac44-8706-4245-87d4-c76a93dd1578","type":"Family","rdfs:label":"UZL1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9541855c-b8d5-4aaa-aada-c7e7f0a3ba84"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"cafe au lait spots, multiple lipomas, macrocephaly, noonan-like face, mild pectus excavatum, hemihyperplasia, pseudotumor orbitae","phenotypePositiveAllelePositive":21,"phenotypes":"obo:HP_0000957","proband":{"id":"https://genegraph.clinicalgenome.org/r/9541855c-b8d5-4aaa-aada-c7e7f0a3ba84"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3ece52db-64a3-4e33-a8dc-0458c651d2bf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL2","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/3ece52db-64a3-4e33-a8dc-0458c651d2bf","type":"Family","rdfs:label":"UZL2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/bd90cdc8-69ed-412f-8205-803f0ed5f082"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"cataract, multiple lipomas, non-small cell lung cancer, learning problems, ADHD, eczema, slow psychomotor development","phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0000518","proband":{"id":"https://genegraph.clinicalgenome.org/r/bd90cdc8-69ed-412f-8205-803f0ed5f082"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/637bfdbb-6c8c-449f-a3d8-437c30aa2a09_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL5","family":{"id":"https://genegraph.clinicalgenome.org/r/637bfdbb-6c8c-449f-a3d8-437c30aa2a09","type":"Family","rdfs:label":"UZL5","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/68aef5ff-a5d7-493c-9d63-13caf0d99691"}},"phenotypeFreeText":"Wilms tumor, tubular colonadenoma, paroxysmal, atrial tachycardia, two lipomas","phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0002667","proband":{"id":"https://genegraph.clinicalgenome.org/r/68aef5ff-a5d7-493c-9d63-13caf0d99691"}},{"id":"https://genegraph.clinicalgenome.org/r/c3c2250b-980c-4adf-8956-a66f0fd49124_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL4","family":{"id":"https://genegraph.clinicalgenome.org/r/c3c2250b-980c-4adf-8956-a66f0fd49124","type":"Family","rdfs:label":"UZL4","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/78212322-92eb-41da-a113-5f1f1e76ad2f"}},"phenotypeFreeText":"Noonan-like face, loose integument, two lipomas, appendicular skin tumor, VUJ-stenosis, nephrolithiasis","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0001012","proband":{"id":"https://genegraph.clinicalgenome.org/r/78212322-92eb-41da-a113-5f1f1e76ad2f"}},{"id":"https://genegraph.clinicalgenome.org/r/f375ccb6-988a-4880-824f-14fd7c4f9d6e_proband_segregation","type":"FamilyCosegregation","dc:description":"There is no information about the variant segregating in this family, but there are 4 affected individuals","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"UZL3","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/f375ccb6-988a-4880-824f-14fd7c4f9d6e","type":"Family","rdfs:label":"UZL3","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c937234b-d135-4b00-a10a-aee015fcd927"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"learning problems, mild supravalvular pulmonic stenosis, learning problems, mild pectus excavatum, learning problems, features consisent with Noonan syndrome","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0000767","proband":{"id":"https://genegraph.clinicalgenome.org/r/c937234b-d135-4b00-a10a-aee015fcd927"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11d4272d-6399-4d1d-bc12-110107b4c3bf","type":"EvidenceLine","dc:description":"This mouse model has craniofacial abnormalities and pigment abnormalities that may be representative of the Legius syndrome phenotype considering this mouse also had RAS phosphorylation alterations. However, the melanin deposits were located in the spleen and there was no mention of the pitmentation abnormalities similar to CAL spots in humans. Furthermore, the homozygosity of the mouse model prevents the mouse from being fully scored.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84eaca9c-4c6c-4467-ae2f-2bbb33855740","type":"Finding","dc:description":"The facial dysmorphisms and pigment abnormalities may be related to the Legius syndrome phenotype. Additionally the RAS pathway abnormalities","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"Knockout Spred1 -/- mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96c31777-f2ab-4a91-966c-be5c86a729aa","type":"EvidenceLine","dc:description":"Since they assayed several different alleles, all of which had been found in patients including the p.I81_V85del, p.M266fsX4, p.R325X, and p.S149N alleles and they quantiifed their impact at several different points in the pathway this experiment showing linkage of this RASopathy to the RAS pathway has been upgraded.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1eca62c-7224-40da-9ce8-e321b562e098","type":"FunctionalAlteration","dc:description":"Phosphorylation assays of several different proteins involved in the RAS/MAPK pathway including MEK, ERK showed that the insufficiency of these alleles led to increased activation of the RAS signaling pathway which has been linked to RASopathies previously","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17704776","rdfs:label":"LOF variants impact phosphorylation of RAS pathway"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3ba44430-8f71-4b94-a6f1-7f66d3a27897_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5159d723-79e7-4f7e-a7d7-4340d7473a6e","type":"EvidenceLine","dc:description":"The interactions  between SPRED1 and BRAF/KRAS are important because both of these proteins have been definitively involved in RASopathies. However, we have already awarded points for SPRED1 impacting the RAS/MAPK pathway and therefore providing evidence that Legius syndrome is a RASopathy. This study does not add information explaining how the alteration of the protein causes the phenotype.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8db0aaa-d863-4cee-8b93-aad7dc5b8379","type":"Finding","dc:description":"SPRED1 was found to coimunnoprecipitate with BRAF because it forms a complex with the protein product. They also found that SPRED1 selectively disturbs the membrane anchorage of K-ras and not H-ras. These interactions are important because both of these proteins have been definitively involved in RASopathies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27503857","rdfs:label":"SPRED1 interaction with RAF, KRAS, HRAS","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7d95c535-d860-4fce-807e-918efadc9883","type":"EvidenceLine","dc:description":"SPRED1 human embryonic kidney cell lysates were found to coimunnoprecipitate with NF1 by binding to the GAP related domain of NF1. NF1 is definitively associated with the RASopathy, neurofibromatosis which is similar to Legius syndrome with the exception that Legius syndrome does not present with neurofibromatic tumors","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9296ecf-2a25-410f-9b6f-ab2942d4d0d6","type":"Finding","dc:description":"SPRED1 human embryonic kidney cell lysates were found to coimunnoprecipitate with NF1 by binding to the GAP related domain of NF1. NF1 is definitively associated with the RASopathy, neurofibromatosis which is similar to Legius syndrome with the exception that Legius syndrome does not present with neurofibromatic tumors","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27313208","rdfs:label":"SPRED1 binds NF1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":201,"specifiedBy":"GeneValidityCriteria6","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/MmSW_ZIN8Kc","type":"GeneValidityProposition","disease":"obo:MONDO_0012669","gene":"hgnc:20249","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3ba44430-8f71-4b94-a6f1-7f66d3a27897-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}